Analysis of colorectal cancer and lung cancer patients showed a similar trend toward beneficial effects associated with DPP4 inhibition (54); however, further studies are required on the clinical impact of DPP4 inhibition on tumor patients. This evidence concerns the gene DPP4 and lung carcinoma.